
|Articles|June 1, 2012
- Pharmaceutical Executive-06-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2012
2012 Dealmakers Roundtable
Advertisement
Articles in this issue
almost 14 years ago
Gamification Grows Upalmost 14 years ago
Raising the Stakes in CNSalmost 14 years ago
A Brand Positioning Nightmarealmost 14 years ago
Europe Responds to Medical Device 'Crisis'almost 14 years ago
Marketing: Medical Devices vs. Pharmaalmost 14 years ago
Innovation and Collaborationalmost 14 years ago
From the Editor:The Connections GameNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5




